Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Fabbro, D., Cowan-Jacob, S. W. & Moebitz, H. Ten things you should know about protein kinases: IUPHAR review 14. Br. J. Pharmacol. 172, 2675–2700 (2015).
2. Blue Ridge Institute for Medical Research: FDA-approved protein kinase inhibitors compiled by Robert Roskoski Jr.
http://www.brimr.org/PKI/PKIs.htm
.
3. Klaeger, S. et al. The target landscape of clinical kinase drugs. Science 358, (2017)
https://doi.org/10.1126/science.aan4368
.
4. Fabian, M. A. et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat. Biotechnol. 23, 329–336 (2005).
5. Fedorov, O. et al. A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc. Natl Acad. Sci. USA 104, 20523–20528 (2007).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献